Praxair (PX) Tops Q1 EPS by 9c, Beats on Revenues

Praxair (NYSE: PX) reported Q1 EPS of $1.65, $0.09 better than the analyst estimate of $1.56. Revenue for the quarter came in at $3 billion versus the consensus estimate of $2.94 billion.

Financial Highlights

• Sales $3.0 billion, 10% above prior-year quarter
• Operating profit $0.7 billion, 15% above prior-year quarter, adjusted operating profit 17% higher
• EPS $1.59, up 18% versus prior-year quarter, adjusted EPS of $1.65, up 20% versus prior-year quarter
• Stable backlog of $1.5 billion:
  • ($0.5) billion of start-ups, including Yara Freeport LLC
  • +$0.5 billion of new wins, including largest-ever investment in one project

Continued Progress on Merger with Linde AG

• Regulatory filings progressing
• Received indicative bids

For earnings history and earnings-related data on Praxair (PX) click here.

You May Also Be Interested In

• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
• Why JPM thinks rising bond yields won’t derail the equity rally
• Designer Brands (DBI) PT Lowered to $6 at UBS